Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy.

Narita, T; Ri, M; Masaki, A; Mori, F; Ito, A; Kusumoto, S; Ishida, T; Komatsu, H; Iida, S

Narita, T; Ri, M; Masaki, A; Mori, F; Ito, A; Kusumoto, S; Ishida, T; Komatsu, H; Iida, S.

Narita T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Ri M; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Masaki A; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Mori F; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Ito A; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Kusumoto S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Ishida T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Komatsu H; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Iida S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.

Blood Cancer J ; 5: e373, 2015 Dec 04.

Article en En | MEDLINE | ID: mdl-26636288

Asunto(s)

Factor de Transcripción Activador 3/metabolismo; Factor de Transcripción Activador 4/metabolismo; Bortezomib/uso terapéutico; Dexametasona/uso terapéutico; Mieloma Múltiple/tratamiento farmacológico; Mieloma Múltiple/genética; Apoptosis; Biomarcadores; Línea Celular Tumoral; Supervivencia sin Enfermedad; Quimioterapia Combinada; Humanos; Proteínas Proto-Oncogénicas c-bcl-2/genética; ARN Mensajero/genética; Receptores del Ligando Inductor de Apoptosis Relacionado con TNF/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Dexametasona / Factor de Transcripción Activador 3 / Factor de Transcripción Activador 4 / Bortezomib / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2015 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google